Advertisement

 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Oncology

   News

 

 Conferences


   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links

advertisement.gif (61x7 -- 0 bytes)

   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 Headlines:

 

 

 

Back to index

Cancer Chemotherapy Regimen for Lymphoma Cancer


 COMLA                                                lymphoma(89)
 _________________________________________________________________
  cytoxan......... 1,500 mg/sqm IV day 1.
  vincristine..... 1.4 mg/sqm IV on days 1, 8, and 15.
  methotrexate.... 120 mg/sqm IV at 3 weeks (day 22) then weekly 
                   times 7 (days 29, 36, 43, 50, 57, 64, and 71).
  leucovorin...... 25 mg/sqm orally every 6 hours times four 
                   starting 24 h after each dose of methotrexate.
  cytarabine...... 300 mg/sqm IV at 3 weeks (day 22), then weekly 
                   times 7 (days 29, 36, 43, 50, 57, 64, and 71).
  FREQUENCY....... Repeat cycle every 13 weeks (91 days).

  reference...
    Berd D.  Cornog J.  DeConti RC.  Levitt M.  Bertino JR. 
    Long-term remission in diffuse histiocytic lymphoma treated 
    with combination sequential chemotherapy. Cancer.  
    35(4):1050-4, 1975 Apr. 
  abstract...
    Seventeen patients with Stage III or IV reticulum cell sarcoma 
    were treated with three cycles of a 5-drug regimen between 
    February, 1969 and December, 1970. Of the 17 patients, 9 
    attained a complete remission and 6 had a parital remission; 2 
    were considered unevaluable. Recently, the original biopsies 
    from these patients were reclassified according to the 
    criteria of rappaport et al. The results were: diffuse 
    histiocytic--8; nodular histiocytic--2; diffuse mixed--2; 
    nodular mixed--3; diffuse lymphocytic poorly 
    differentiated--1; nodular lymphocytic poorly 
    differentiated--1. Of the 8 patients with diffuse histiocytic 
    lymphoma 6 attained complete remission, 1 had a partial 
    remission, and 1 was unevaluable. One of the 6 with complete 
    remission relapsed at 7 months and died 2 months later. 
    However, the other 5 are alive and in continued unmaintained 
    remission for 55 to 65 months. 
 

advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


 

 advertisement.gif (61x7 -- 0 bytes)

 

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright © 2001-2007 The Doctors Lounge. All rights reserved.